Hostname: page-component-74656f9884-kv2lp Total loading time: 0 Render date: 2026-11-05T21:44:38.635Z Has data issue: false hasContentIssue false

The Multilingual Naming Test in Alzheimer's Disease: Clues to the Origin of Naming Impairments

Published online by Cambridge University Press:  08 January 2013

Iva Ivanova
Affiliation:
Department of Psychiatry, University of California, San Diego, La Jolla, California
David P. Salmon
Affiliation:
Department of Neurosciences, University of California, San Diego, La Jolla, California
Tamar H. Gollan*
Affiliation:
Department of Psychiatry, University of California, San Diego, La Jolla, California
*
Correspondence and reprint requests to: Tamar H. Gollan, 9500 Gilman Drive, 0948, Department of Psychiatry, University of California, San Diego, La Jolla, CA 92093-0948. E-mail: tgollan@ucsd.edu
Rights & Permissions [Opens in a new window]

Abstract

The current study explored the picture naming performance of patients with Alzheimer's disease (AD). First, we evaluated the utility of the Multilingual Naming Test (MINT; Gollan et al., 2011), which was designed to assess naming skills in speakers of multiple languages, for detecting naming impairments in monolingual AD and amnestic mild cognitive impairment (MCI). If the MINT were sensitive to linguistic impairment in AD, using it in clinical practice might have advantages over using tests exclusively designed for English monolinguals. We found that the MINT can be used with both monolinguals and bilinguals: A 32-item subset of the MINT is best for distinguishing monolingual patients from controls, while the full MINT is best for assessing degree of bilingualism and language dominance in bilinguals. We then investigated the cognitive mechanisms underlying naming impairment in AD. To this end, we explored which MINT item characteristics best predicted performance differences between monolingual patients and controls. We found that contextual diversity and imageability, but not word frequency (nor words’ number of senses), contributed unique variance to explaining naming impairments in AD. These findings suggest a semantic component to the naming impairment in AD (modulated by names’ semantic richness and network size). (JINS, 2013, 19, 1–12)

Information

Type
Research Articles
Copyright
Copyright © The International Neuropsychological Society 2012
Figure 0

Table 1 Means, standard deviations and comparisons for all participants’ characteristics

Figure 1

Table 2 MINT picture name characteristics

Figure 2

Table 3a Means (proportion correct), standard deviations and pairwise comparisons of monolingual participants’ scores on the full MINT, the 32-item subset of the MINT, and a 30-item version of the BNT

Figure 3

Table 3b Means (proportion correct) standard deviations and pairwise comparisons of bilingual participants’ scores on the full MINT, the 32-item subset of the MINT, and a 30-item version of the BNT

Figure 4

Fig. 1 (a) Bilingual index scores derived from self-ratings, the full MINT, the 32-item MINT and the BNT. (b) Language dominance scores derived from self-ratings, the full MINT, the 32-item MINT and the BNT. MINT = Multilingual Naming Test; BNT = Boston Naming Test.

Figure 5

Table 4 Results of multiple regression analyses for the difference in naming performance between patients with probable AD and controls

Figure 6

Fig. 2 Correlations between the accuracy differences (in proportions) between AD patients and controls for each of the MINT items, and the word frequency (a), contextual diversity (b), number of senses (c) and imageability (d) of the items. AD – patients with probable Alzheimer's disease; NC – normal controls.

Figure 7

Table 5 Pearson bivariate correlations between the different MINT item characteristics

Figure 8

APPENDIX List of the items comprising the MINT, and item scores by group